A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.
See omnystudio.com/listener for privacy information.
41: Hershey Still Standing as Mondelez Deal Melts Away
40: The M&A Coverage Conundrum
39: Formula One Sale Begets Questions About Sport's Future
38: Gawker Banker Says Ziff Davis Has 'Earned' Right to Buy It
37: Is Uber Failing with Its $35 Billion Didi Merger?
36: Yahoo May Just Be The Beginning for Verizon
35: Will SoftBank's ARM Deal Derail Sprint's T-Mobile Plan?
34: UFC's Rise to $4 Billion From $2 Million
33: Hershey Considers More Than Money as Mondelez Makes Offer
32: Why Pharmaceutical Companies Face an Existential M&A Crisis
31: SoftBank Makes Billions on Supercell Sale (Correct)
30: Microsoft's LinkedIn Purchase Is Hardly a Sure Thing
29: Even You Can Profit from Merger Arbitrage!
28: Big Money Utility Deals May Lead 2016 M&A
27: Monsanto Dances with Bayer; George Zimmer Wants Back In
26: Why Warren Buffett's Bet on Yahoo Deal Probably Makes Sense
25: Tribune's Questionable Case to Fight Off Gannett
24: Another One Bites The Dust
23: The Brazil-Born, Texas-Bred Banker Who Loved Basketball
22: Why In the World Does Verizon Want to Buy Yahoo?
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Masters in Business
Odd Lots
Bloomberg Surveillance
Bloomberg Businessweek
Prognosis: Losing it